Company intelligence / Profile preview

Perigon Pharmacy

Ownership: Private
Development stage: Other

Overview

Perigon provides nationwide specialty pharmacy services with a focus on rare disease therapies. The company offers advanced technology solutions for patient engagement and adherence and has invested in ultra-low temperature storage to support cell and gene therapy distribution. It maintains high standards of clinical care as evidenced by dual ACHC & URAC accreditation and reports an industry-leading Net Promoter Score of 82%[2][3].

Therapeutic areas: Rare Diseases
Modalities: Cell therapyGene therapyBiologic
Industry: Non-Academic Healthcare

Partnerships

Collaborates with biopharmaceutical manufacturers for patient access programs[2]

Beyond the preview

Go deeper on Perigon Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perigon Pharmacy.

Explore the full profile